GCP
GHDX
GSA Capital Partners’s Genomic Health, Inc. GHDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-19,460
| Closed | -$1.32M | – | 1880 |
|
2019
Q3 | $1.32M | Sell |
19,460
-31,975
| -62% | -$2.17M | 0.18% | 78 |
|
2019
Q2 | $2.99M | Sell |
51,435
-2,430
| -5% | -$141K | 0.34% | 14 |
|
2019
Q1 | $3.77M | Buy |
53,865
+5,565
| +12% | +$390K | 0.38% | 11 |
|
2018
Q4 | $3.11M | Sell |
48,300
-30,900
| -39% | -$1.99M | 0.36% | 28 |
|
2018
Q3 | $5.56M | Sell |
79,200
-16,700
| -17% | -$1.17M | 0.31% | 10 |
|
2018
Q2 | $4.83M | Buy |
95,900
+51,600
| +116% | +$2.6M | 0.24% | 31 |
|
2018
Q1 | $1.39M | Buy |
44,300
+23,000
| +108% | +$720K | 0.07% | 464 |
|
2017
Q4 | $728K | Sell |
21,300
-41,800
| -66% | -$1.43M | 0.04% | 753 |
|
2017
Q3 | $2.03M | Buy |
63,100
+19,200
| +44% | +$616K | 0.14% | 149 |
|
2017
Q2 | $1.43M | Buy |
43,900
+28,800
| +191% | +$937K | 0.09% | 302 |
|
2017
Q1 | $475K | Sell |
15,100
-16,100
| -52% | -$506K | 0.03% | 1127 |
|
2016
Q4 | $917K | Sell |
31,200
-25,813
| -45% | -$759K | 0.05% | 604 |
|
2016
Q3 | $1.65M | Buy |
57,013
+12,645
| +29% | +$366K | 0.09% | 323 |
|
2016
Q2 | $1.15M | Sell |
44,368
-61,783
| -58% | -$1.6M | 0.06% | 544 |
|
2016
Q1 | $2.63M | Sell |
106,151
-6,109
| -5% | -$151K | 0.17% | 95 |
|
2015
Q4 | $3.95M | Buy |
112,260
+7,512
| +7% | +$264K | 0.19% | 63 |
|
2015
Q3 | $2.22M | Sell |
104,748
-38,802
| -27% | -$821K | 0.11% | 220 |
|
2015
Q2 | $3.99M | Buy |
143,550
+40,533
| +39% | +$1.13M | 0.15% | 87 |
|
2015
Q1 | $3.15M | Buy |
103,017
+38,800
| +60% | +$1.19M | 0.13% | 140 |
|
2014
Q4 | $2.05M | Buy |
64,217
+21,485
| +50% | +$687K | 0.14% | 143 |
|
2014
Q3 | $1.21M | Buy |
42,732
+13,500
| +46% | +$382K | 0.06% | 380 |
|
2014
Q2 | $801K | Buy |
29,232
+10,803
| +59% | +$296K | 0.04% | 819 |
|
2014
Q1 | $485K | Sell |
18,429
-19,393
| -51% | -$510K | 0.03% | 802 |
|
2013
Q4 | $1.11M | Buy |
37,822
+1,490
| +4% | +$43.6K | 0.09% | 300 |
|
2013
Q3 | $1.11M | Buy |
36,332
+4,900
| +16% | +$150K | 0.09% | 300 |
|
2013
Q2 | $997K | Buy |
+31,432
| New | +$997K | 0.12% | 218 |
|